Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | UK Research & Innovation |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): |
Awarded to
| Award value: | £749,376 |
| Award decision date: | 2 May 2023 |
| Award status: | Active |
The UK Rare Disease Research Platform (UK-RDRP) is being established by MRC and NIHR to connect and enhance the UK's strengths in rare disease research. Rare diseases are defined as diseases with a prevalence of less than one in 2000 individuals, and include disease of genetic and non-genetic origins. The aim of the Platform is to underpin greater collaboration between academic, clinical and industry research with essential patients, research charities and other stakeholders to accelerate the understanding, diagnosis and therapy of rare diseases. The Platform will support networking and activities that enable research and will comprise a number of challenge-led thematic nodes (each led by UK research organisations, e.g. universities), with a single, integrated platform Hub.
Published contracts in the last 12 months
41
total contracts
£10.4m
total value
£651,509
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
2 May 2023
Closed
Estimated Value
£749,376
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| £749,376 |
| Release Date: | 24 May 2023 |
| Application Deadline: | 2 May 2023 |
| Contract Start Date: | 17 May 2023 |
| Contract End Date: | 18 May 2028 |
| Contract Duration: | 5.1 years |
| Procurement ID (OCID): | ocds-b5fd17-88d620c7-15b5-4077-a114-f425c4f898be |
| Notice Reference: | 87794547-8aad-4977-b908-07962cc114ff-647678 |
View Original Notice
Access the full notice on the official portal